ANRO logo

Alto Neuroscience (ANRO) Company Overview

Profile

Full Name:

Alto Neuroscience

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

February 2, 2024

Indexes:

Not included

Description:

Alto Neuroscience is a company focused on developing innovative treatments for mental health conditions. They use advanced technology and research to create personalized therapies that aim to improve brain health and overall well-being. Their goal is to help people manage mental health challenges more effectively.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 28, 2025

Recent annual earnings:

Feb 28, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 16, 24 Jones Trading
Buy
Nov 13, 24 Stifel
Buy
Oct 23, 24 Wedbush
Neutral
Oct 23, 24 Baird
Outperform
Sep 10, 24 Wedbush
Outperform
Sep 3, 24 Wedbush
Outperform
Jun 21, 24 Rodman & Renshaw
Buy
Mar 25, 24 Stifel
Buy
Feb 27, 24 Stifel
Buy
Feb 27, 24 Jefferies
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Alto Neuroscience?
  • Does Alto Neuroscience pay dividends?
  • What sector is Alto Neuroscience in?
  • What industry is Alto Neuroscience in?
  • What country is Alto Neuroscience based in?
  • When did Alto Neuroscience go public?
  • Is Alto Neuroscience in the S&P 500?
  • Is Alto Neuroscience in the NASDAQ 100?
  • Is Alto Neuroscience in the Dow Jones?
  • When was Alto Neuroscience's last earnings report?
  • When does Alto Neuroscience report earnings?
  • Should I buy Alto Neuroscience stock now?

What is the ticker symbol for Alto Neuroscience?

The ticker symbol for Alto Neuroscience is NYSE:ANRO

Does Alto Neuroscience pay dividends?

No, Alto Neuroscience does not pay dividends

What sector is Alto Neuroscience in?

Alto Neuroscience is in the Healthcare sector

What industry is Alto Neuroscience in?

Alto Neuroscience is in the Biotechnology industry

What country is Alto Neuroscience based in?

Alto Neuroscience is headquartered in United States

When did Alto Neuroscience go public?

Alto Neuroscience's initial public offering (IPO) was on February 2, 2024

Is Alto Neuroscience in the S&P 500?

No, Alto Neuroscience is not included in the S&P 500 index

Is Alto Neuroscience in the NASDAQ 100?

No, Alto Neuroscience is not included in the NASDAQ 100 index

Is Alto Neuroscience in the Dow Jones?

No, Alto Neuroscience is not included in the Dow Jones index

When was Alto Neuroscience's last earnings report?

Alto Neuroscience's most recent earnings report was on Feb 28, 2025

When does Alto Neuroscience report earnings?

The date for Alto Neuroscience's next earnings report has not been announced yet

Should I buy Alto Neuroscience stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions